{"id":5312,"date":"2025-05-12T10:18:05","date_gmt":"2025-05-12T17:18:05","guid":{"rendered":"https:\/\/molecularf.wpenginepowered.com\/molecular-forecaster-et-oxeltis-sassocient-pour-accelerer-la-conception-de-medicaments\/"},"modified":"2026-09-18T17:52:54","modified_gmt":"2026-09-19T00:52:54","slug":"molecular-forecaster-et-oxeltis-sassocient-pour-accelerer-la-conception-de-medicaments","status":"publish","type":"post","link":"https:\/\/molecularforecaster.com\/fr\/molecular-forecaster-et-oxeltis-sassocient-pour-accelerer-la-conception-de-medicaments\/","title":{"rendered":"Molecular Forecaster et Oxeltis s&rsquo;associent pour acc\u00e9l\u00e9rer la conception de m\u00e9dicaments"},"content":{"rendered":"\n<div class=\"et_pb_section_0 et_pb_section et_section_regular et_block_section\"><div class=\"et_pb_row_0 et_pb_row et_block_row\"><div class=\"et_pb_column_0 et_pb_column et_pb_column_4_4 et-last-child et_block_column et_pb_css_mix_blend_mode_passthrough\"><div class=\"et_pb_text_0 et_pb_text et_pb_bg_layout_light et_pb_module et_block_module\"><div class=\"et_pb_text_inner\"><h1><strong><span data-contrast=\"auto\" xml:lang=\"EN-CA\" lang=\"EN-CA\" class=\"TextRun SCXW166256516 BCX0\"><span class=\"NormalTextRun SCXW166256516 BCX0\">Pr\u00e9visionniste mol\u00e9culaire<\/span><span class=\"NormalTextRun SCXW166256516 BCX0\"> et <\/span><span class=\"NormalTextRun SpellingErrorV2Themed SCXW166256516 BCX0\">Oxeltis<\/span><span class=\"NormalTextRun SCXW166256516 BCX0\"> \u00e9tablissent une collaboration strat\u00e9gique afin d'am\u00e9liorer l'efficacit\u00e9 de leurs clients dans le domaine des m\u00e9dicaments. <\/span><span class=\"NormalTextRun SCXW166256516 BCX0\">m\u00e9dicaments<\/span><span class=\"NormalTextRun SCXW166256516 BCX0\"> conception et <\/span><span class=\"NormalTextRun SCXW166256516 BCX0\">synth\u00e8se<\/span><\/span><span class=\"EOP SCXW166256516 BCX0\" data-ccp-props=\"{\"201341983\":0,\"335559739\":0,\"335559740\":240}\"> <\/span><\/strong><\/h1>\n<p><strong><span class=\"EOP SCXW166256516 BCX0\" data-ccp-props=\"{\"201341983\":0,\"335559739\":0,\"335559740\":240}\"><\/span><\/strong><\/p>\n<p><strong>MONTR\u00c9AL, CANADA, et MONTPELLIER, FRANCE, 12 mai 2025<\/strong><span data-contrast=\"auto\"> -<strong> Molecular<\/strong> Forecaster Inc. (MFI) et Oxeltis S.A. (Oxeltis) sont heureux d'annoncer un partenariat strat\u00e9gique mettant \u00e0 profit les forces des deux organisations afin d'offrir une int\u00e9gration transparente des technologies <\/span><i><span data-contrast=\"auto\">in silico<\/span><\/i><span data-contrast=\"auto\"> de la conception in silico et de la synth\u00e8se chimique de haute qualit\u00e9.<\/span><span data-ccp-props=\"{\"201341983\":0,\"335559739\":0,\"335559740\":240}\"> <\/span><\/p>\n<p><span data-contrast=\"auto\">MFI et Oxeltis se concentrent toutes deux sur l'acc\u00e9l\u00e9ration des \u00e9tapes pr\u00e9cliniques du processus de conception des m\u00e9dicaments. MFI est une organisation de recherche en tant que service (RaaS) combinant l'expertise humaine et la technologie propri\u00e9taire qui int\u00e8gre la chimie et la mod\u00e9lisation computationnelle pour r\u00e9duire les cycles de conception dans les campagnes de petites mol\u00e9cules. Oxeltis propose des services de chimie m\u00e9dicinale et organique fine pour la recherche en sciences de la vie, y compris l'optimisation des candidats pr\u00e9cliniques, la synth\u00e8se \u00e0 fa\u00e7on et le rep\u00e9rage des voies de passage \u00e0 l'\u00e9chelle sup\u00e9rieure.  <\/span><span data-ccp-props=\"{\"201341983\":0,\"335559739\":0,\"335559740\":240}\"> <\/span><\/p>\n<p><span data-contrast=\"auto\">\"Chez MFI, nous pensons que le principal avantage de la conception computationnelle de m\u00e9dicaments est d'aider les humains \u00e0 apprendre plus rapidement afin qu'ils puissent prendre des d\u00e9cisions plus intelligentes et plus strat\u00e9giques qui permettent d'\u00e9conomiser du temps, de l'argent et des vies\", d\u00e9clare Josh Pottel, directeur g\u00e9n\u00e9ral de MFI. \"Nous pensons \u00e9galement que la collaboration est essentielle pour obtenir les meilleurs r\u00e9sultats possibles. L'\u00e9tablissement de relations compl\u00e9mentaires, comme celle que nous avons avec Oxeltis, correspond \u00e0 nos valeurs et \u00e0 notre fa\u00e7on de travailler, et nous sommes impatients de voir o\u00f9 nous allons aller ensemble.\"   <\/span><span data-ccp-props=\"{\"201341983\":0,\"335559739\":0,\"335559740\":240}\"> <\/span><\/p>\n<p><span data-contrast=\"auto\">Dans le cadre de cette collaboration, MFI et Oxeltis aideront les entreprises \u00e0 hi\u00e9rarchiser les candidats, \u00e0 r\u00e9duire les cycles de conception et \u00e0 accro\u00eetre la productivit\u00e9 en int\u00e9grant la mod\u00e9lisation pr\u00e9dictive et les solutions CADD personnalis\u00e9es et collaboratives de MFI \u00e0 la conception et \u00e0 la synth\u00e8se de la chimie m\u00e9dicinale en laboratoire humide d'Oxeltis. Ce partenariat strat\u00e9gique profitera \u00e9galement aux clients en rationalisant la gestion et l'administration des projets entre les organisations, sans sacrifier l'expertise individuelle de l'une ou l'autre d'entre elles. <\/span><span data-ccp-props=\"{\"201341983\":0,\"335559739\":0,\"335559740\":240}\"> <\/span><\/p>\n<p><span data-contrast=\"auto\">\"Cette collaboration est l'occasion d'externaliser des activit\u00e9s de recherche critiques \u00e0 des entreprises disposant d'une expertise de recherche hautement sp\u00e9cialis\u00e9e et compl\u00e9mentaire, et d'une relation de travail \u00e9prouv\u00e9e et productive \", d\u00e9clare Jean-Marc Allaire, PDG d'Oxeltis. \"Que les organisations aient besoin de campagnes de criblage virtuel, de la synth\u00e8se de biblioth\u00e8ques cibl\u00e9es ou d'un soutien enti\u00e8rement int\u00e9gr\u00e9 pour les programmes de d\u00e9couverte pr\u00e9coce, nos connaissances et nos approches combin\u00e9es nous permettent de personnaliser des solutions innovantes et efficaces pour les clients qui les mettent sur la voie du plus grand succ\u00e8s.\" <\/span><span data-ccp-props=\"{\"201341983\":0,\"335559739\":0,\"335559740\":240}\"> <\/span><\/p>\n<p><span data-contrast=\"auto\">Pour en savoir plus sur la mani\u00e8re dont le partenariat MFI-Oxeltis peut soutenir les projets de conception de m\u00e9dicaments \u00e0 un stade pr\u00e9coce, l'\u00e9quipe d'Oxeltis participera \u00e0 la conf\u00e9rence suivante <\/span><a href=\"https:\/\/www.medchemfrontiers.org\/\"><span data-contrast=\"none\">Fronti\u00e8res de la chimie m\u00e9dicinale ACSMEDI-EFMC<\/span><\/a><span data-contrast=\"auto\">  \u00e0 Chicago, du 12 au 15 mai 2025, et les deux \u00e9quipes seront pr\u00e9sentes \u00e0 BIO \u00e0 Boston, du 16 au 19 juin. Vous pouvez organiser une discussion \u00e0 l'adresse suivante   <\/span><a href=\"mailto:contact@oxeltis.com\"><span data-contrast=\"none\">contact@oxeltis.com<\/span><\/a><span data-contrast=\"auto\"> ou en envoyant un courriel \u00e0 l'\u00e9quipe de l'IMF \u00e0 l'adresse suivante <\/span><a href=\"mailto:info@molecularforecaster.com\"><span data-contrast=\"none\">info@molecularforecaster.com<\/span><\/a><span data-contrast=\"auto\">.<\/span><span data-ccp-props=\"{\"335559739\":0}\"> <\/span><\/p>\n<p style=\"text-align: center;\"><span data-contrast=\"auto\">-\/\/-<\/span><span data-ccp-props=\"{\"201341983\":0,\"335551550\":2,\"335551620\":2,\"335559739\":0,\"335559740\":240}\"> <\/span><\/p>\n<p style=\"text-align: center;\"><span data-ccp-props=\"{\"201341983\":0,\"335551550\":6,\"335551620\":6,\"335559739\":0,\"335559740\":240}\"> <\/span><\/p>\n<h4><b><span data-contrast=\"auto\">A PROPOS DE L'IMF<\/span><\/b><span data-ccp-props=\"{\"201341983\":0,\"335559739\":0,\"335559740\":240}\"> <\/span><\/h4>\n<p><span data-contrast=\"auto\">Molecular Forecaster Inc. (MFI) aide les organisations \u00e0 prendre des d\u00e9cisions plus intelligentes en mati\u00e8re de conception de m\u00e9dicaments. Depuis six ans, nous d\u00e9mocratisons la conception de m\u00e9dicaments assist\u00e9e par ordinateur gr\u00e2ce \u00e0 notre service de recherche hautement collaboratif.   <\/span><span data-contrast=\"auto\">mod\u00e8le. Aujourd'hui, nous int\u00e9grons ce que nous avons appris dans des outils logiciels nouveaux et am\u00e9lior\u00e9s. Notre objectif ? Devenir le partenaire de r\u00e9f\u00e9rence en mati\u00e8re de conception de m\u00e9dicaments \u00e0 base de petites mol\u00e9cules, en combinant des outils et des technologies exclusifs, notre expertise et notre savoir-faire, ainsi que notre approche globale de la collaboration, qui place nos partenaires sur la voie de la r\u00e9ussite.   <\/span><span data-ccp-props=\"{\"201341983\":0,\"335559739\":0,\"335559740\":240}\"> <\/span><\/p>\n<h4><b><span data-contrast=\"auto\">\u00c0 PROPOS D'OXELTIS  <\/span><\/b><span data-ccp-props=\"{\"201341983\":0,\"335559739\":0,\"335559740\":240}\"> <\/span><\/h4>\n<p><span data-contrast=\"auto\">Oxeltis est une organisation de recherche sous contrat (CRO) sp\u00e9cialis\u00e9e dans la chimie m\u00e9dicinale et la chimie organique fine, avec plus de 15 ans d'exp\u00e9rience dans les compos\u00e9s organiques hautement fonctionnalis\u00e9s. Notre \u00e9quipe de chimistes se concentre sur plusieurs plates-formes technologiques de base : H\u00e9t\u00e9rocycles, Nucleos(t)ides, Phosphoramidites, Peptides, Oligosaccharides, Linkers, PROTACs, et route scouting, avec des capacit\u00e9s de synth\u00e8se allant de mg \u00e0 100g.   <\/span><span data-contrast=\"auto\">Au cours de la derni\u00e8re d\u00e9cennie, Oxeltis a \u00e9t\u00e9 un partenaire de confiance dans des programmes de d\u00e9couverte de m\u00e9dicaments pour des entreprises et des instituts internationaux, y compris cinq des dix plus grands groupes pharmaceutiques, ainsi que des biotechnologies innovantes d'Europe, d'Isra\u00ebl, d'Am\u00e9rique du Nord et du Japon. Notre engagement en faveur de l'excellence et de la fiabilit\u00e9 ( <\/span><span data-contrast=\"auto\">accr\u00e9ditation ISO 9001) <\/span><span data-contrast=\"auto\">nous a valu la r\u00e9putation de fournir des r\u00e9sultats de haute qualit\u00e9 qui stimulent le progr\u00e8s scientifique.<\/span><span data-ccp-props=\"{\"201341983\":0,\"335559739\":0,\"335559740\":240}\"> <\/span><\/p>\n<p>&nbsp;<\/p>\n<p><span data-ccp-props=\"{\"201341983\":0,\"335559739\":0,\"335559740\":240}\"><\/span><\/p>\n<p><span data-ccp-props=\"{\"201341983\":0,\"335559739\":0,\"335559740\":240}\"><\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":7,"featured_media":5298,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[19],"tags":[],"class_list":["post-5312","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualites"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Molecular Forecaster et Oxeltis s&#039;associent pour acc\u00e9l\u00e9rer la conception de m\u00e9dicaments - Molecular Forecaster<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/molecularforecaster.com\/fr\/molecular-forecaster-et-oxeltis-sassocient-pour-accelerer-la-conception-de-medicaments\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Molecular Forecaster et Oxeltis s&#039;associent pour acc\u00e9l\u00e9rer la conception de m\u00e9dicaments - Molecular Forecaster\" \/>\n<meta property=\"og:url\" content=\"https:\/\/molecularforecaster.com\/fr\/molecular-forecaster-et-oxeltis-sassocient-pour-accelerer-la-conception-de-medicaments\/\" \/>\n<meta property=\"og:site_name\" content=\"Molecular Forecaster\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-12T17:18:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-19T00:52:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/molecularforecaster.com\/wp-content\/uploads\/2025\/05\/Untitled-design-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"400\" \/>\n\t<meta property=\"og:image:height\" content=\"300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Justin Buschman Dormond\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@molforecaster\" \/>\n<meta name=\"twitter:site\" content=\"@molforecaster\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Justin Buschman Dormond\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/molecular-forecaster-et-oxeltis-sassocient-pour-accelerer-la-conception-de-medicaments\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/molecular-forecaster-et-oxeltis-sassocient-pour-accelerer-la-conception-de-medicaments\\\/\"},\"author\":{\"name\":\"Justin Buschman Dormond\",\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/#\\\/schema\\\/person\\\/2dcf092699b10e5ceff87ec1f4a53e26\"},\"headline\":\"Molecular Forecaster et Oxeltis s&rsquo;associent pour acc\u00e9l\u00e9rer la conception de m\u00e9dicaments\",\"datePublished\":\"2025-05-12T17:18:05+00:00\",\"dateModified\":\"2026-09-19T00:52:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/molecular-forecaster-et-oxeltis-sassocient-pour-accelerer-la-conception-de-medicaments\\\/\"},\"wordCount\":15,\"publisher\":{\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/molecular-forecaster-et-oxeltis-sassocient-pour-accelerer-la-conception-de-medicaments\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/molecularforecaster.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/Untitled-design-1.png\",\"articleSection\":[\"Actualit\u00e9s\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/molecular-forecaster-et-oxeltis-sassocient-pour-accelerer-la-conception-de-medicaments\\\/\",\"url\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/molecular-forecaster-et-oxeltis-sassocient-pour-accelerer-la-conception-de-medicaments\\\/\",\"name\":\"Molecular Forecaster et Oxeltis s'associent pour acc\u00e9l\u00e9rer la conception de m\u00e9dicaments - Molecular Forecaster\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/molecular-forecaster-et-oxeltis-sassocient-pour-accelerer-la-conception-de-medicaments\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/molecular-forecaster-et-oxeltis-sassocient-pour-accelerer-la-conception-de-medicaments\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/molecularforecaster.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/Untitled-design-1.png\",\"datePublished\":\"2025-05-12T17:18:05+00:00\",\"dateModified\":\"2026-09-19T00:52:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/molecular-forecaster-et-oxeltis-sassocient-pour-accelerer-la-conception-de-medicaments\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/molecular-forecaster-et-oxeltis-sassocient-pour-accelerer-la-conception-de-medicaments\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/molecular-forecaster-et-oxeltis-sassocient-pour-accelerer-la-conception-de-medicaments\\\/#primaryimage\",\"url\":\"https:\\\/\\\/molecularforecaster.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/Untitled-design-1.png\",\"contentUrl\":\"https:\\\/\\\/molecularforecaster.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/Untitled-design-1.png\",\"width\":400,\"height\":300},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/molecular-forecaster-et-oxeltis-sassocient-pour-accelerer-la-conception-de-medicaments\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Molecular Forecaster et Oxeltis s&#8217;associent pour acc\u00e9l\u00e9rer la conception de m\u00e9dicaments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/\",\"name\":\"Molecular Forecaster\",\"description\":\"Research-as a-Service to create more certainty in drug discovery\",\"publisher\":{\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/#organization\",\"name\":\"Molecular Forecaster\",\"url\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/molecularforecaster.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/MFI_Logo.png\",\"contentUrl\":\"https:\\\/\\\/molecularforecaster.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/MFI_Logo.png\",\"width\":642,\"height\":260,\"caption\":\"Molecular Forecaster\"},\"image\":{\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/molforecaster\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/molecular-forecaster\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UC3fJ27NvPDqtJ8BgcNApWwA\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/#\\\/schema\\\/person\\\/2dcf092699b10e5ceff87ec1f4a53e26\",\"name\":\"Justin Buschman Dormond\",\"url\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/author\\\/justin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Molecular Forecaster et Oxeltis s'associent pour acc\u00e9l\u00e9rer la conception de m\u00e9dicaments - Molecular Forecaster","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/molecularforecaster.com\/fr\/molecular-forecaster-et-oxeltis-sassocient-pour-accelerer-la-conception-de-medicaments\/","og_locale":"fr_FR","og_type":"article","og_title":"Molecular Forecaster et Oxeltis s'associent pour acc\u00e9l\u00e9rer la conception de m\u00e9dicaments - Molecular Forecaster","og_url":"https:\/\/molecularforecaster.com\/fr\/molecular-forecaster-et-oxeltis-sassocient-pour-accelerer-la-conception-de-medicaments\/","og_site_name":"Molecular Forecaster","article_published_time":"2025-05-12T17:18:05+00:00","article_modified_time":"2026-09-19T00:52:54+00:00","og_image":[{"width":400,"height":300,"url":"https:\/\/molecularforecaster.com\/wp-content\/uploads\/2025\/05\/Untitled-design-1.png","type":"image\/png"}],"author":"Justin Buschman Dormond","twitter_card":"summary_large_image","twitter_creator":"@molforecaster","twitter_site":"@molforecaster","twitter_misc":{"\u00c9crit par":"Justin Buschman Dormond"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/molecularforecaster.com\/fr\/molecular-forecaster-et-oxeltis-sassocient-pour-accelerer-la-conception-de-medicaments\/#article","isPartOf":{"@id":"https:\/\/molecularforecaster.com\/fr\/molecular-forecaster-et-oxeltis-sassocient-pour-accelerer-la-conception-de-medicaments\/"},"author":{"name":"Justin Buschman Dormond","@id":"https:\/\/molecularforecaster.com\/fr\/#\/schema\/person\/2dcf092699b10e5ceff87ec1f4a53e26"},"headline":"Molecular Forecaster et Oxeltis s&rsquo;associent pour acc\u00e9l\u00e9rer la conception de m\u00e9dicaments","datePublished":"2025-05-12T17:18:05+00:00","dateModified":"2026-09-19T00:52:54+00:00","mainEntityOfPage":{"@id":"https:\/\/molecularforecaster.com\/fr\/molecular-forecaster-et-oxeltis-sassocient-pour-accelerer-la-conception-de-medicaments\/"},"wordCount":15,"publisher":{"@id":"https:\/\/molecularforecaster.com\/fr\/#organization"},"image":{"@id":"https:\/\/molecularforecaster.com\/fr\/molecular-forecaster-et-oxeltis-sassocient-pour-accelerer-la-conception-de-medicaments\/#primaryimage"},"thumbnailUrl":"https:\/\/molecularforecaster.com\/wp-content\/uploads\/2025\/05\/Untitled-design-1.png","articleSection":["Actualit\u00e9s"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/molecularforecaster.com\/fr\/molecular-forecaster-et-oxeltis-sassocient-pour-accelerer-la-conception-de-medicaments\/","url":"https:\/\/molecularforecaster.com\/fr\/molecular-forecaster-et-oxeltis-sassocient-pour-accelerer-la-conception-de-medicaments\/","name":"Molecular Forecaster et Oxeltis s'associent pour acc\u00e9l\u00e9rer la conception de m\u00e9dicaments - Molecular Forecaster","isPartOf":{"@id":"https:\/\/molecularforecaster.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/molecularforecaster.com\/fr\/molecular-forecaster-et-oxeltis-sassocient-pour-accelerer-la-conception-de-medicaments\/#primaryimage"},"image":{"@id":"https:\/\/molecularforecaster.com\/fr\/molecular-forecaster-et-oxeltis-sassocient-pour-accelerer-la-conception-de-medicaments\/#primaryimage"},"thumbnailUrl":"https:\/\/molecularforecaster.com\/wp-content\/uploads\/2025\/05\/Untitled-design-1.png","datePublished":"2025-05-12T17:18:05+00:00","dateModified":"2026-09-19T00:52:54+00:00","breadcrumb":{"@id":"https:\/\/molecularforecaster.com\/fr\/molecular-forecaster-et-oxeltis-sassocient-pour-accelerer-la-conception-de-medicaments\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/molecularforecaster.com\/fr\/molecular-forecaster-et-oxeltis-sassocient-pour-accelerer-la-conception-de-medicaments\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/molecularforecaster.com\/fr\/molecular-forecaster-et-oxeltis-sassocient-pour-accelerer-la-conception-de-medicaments\/#primaryimage","url":"https:\/\/molecularforecaster.com\/wp-content\/uploads\/2025\/05\/Untitled-design-1.png","contentUrl":"https:\/\/molecularforecaster.com\/wp-content\/uploads\/2025\/05\/Untitled-design-1.png","width":400,"height":300},{"@type":"BreadcrumbList","@id":"https:\/\/molecularforecaster.com\/fr\/molecular-forecaster-et-oxeltis-sassocient-pour-accelerer-la-conception-de-medicaments\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/molecularforecaster.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Molecular Forecaster et Oxeltis s&#8217;associent pour acc\u00e9l\u00e9rer la conception de m\u00e9dicaments"}]},{"@type":"WebSite","@id":"https:\/\/molecularforecaster.com\/fr\/#website","url":"https:\/\/molecularforecaster.com\/fr\/","name":"Molecular Forecaster","description":"Research-as a-Service to create more certainty in drug discovery","publisher":{"@id":"https:\/\/molecularforecaster.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/molecularforecaster.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/molecularforecaster.com\/fr\/#organization","name":"Molecular Forecaster","url":"https:\/\/molecularforecaster.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/molecularforecaster.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/molecularforecaster.com\/wp-content\/uploads\/2023\/12\/MFI_Logo.png","contentUrl":"https:\/\/molecularforecaster.com\/wp-content\/uploads\/2023\/12\/MFI_Logo.png","width":642,"height":260,"caption":"Molecular Forecaster"},"image":{"@id":"https:\/\/molecularforecaster.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/molforecaster","https:\/\/www.linkedin.com\/company\/molecular-forecaster\/","https:\/\/www.youtube.com\/channel\/UC3fJ27NvPDqtJ8BgcNApWwA"]},{"@type":"Person","@id":"https:\/\/molecularforecaster.com\/fr\/#\/schema\/person\/2dcf092699b10e5ceff87ec1f4a53e26","name":"Justin Buschman Dormond","url":"https:\/\/molecularforecaster.com\/fr\/author\/justin\/"}]}},"_links":{"self":[{"href":"https:\/\/molecularforecaster.com\/fr\/wp-json\/wp\/v2\/posts\/5312","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/molecularforecaster.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/molecularforecaster.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/molecularforecaster.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/molecularforecaster.com\/fr\/wp-json\/wp\/v2\/comments?post=5312"}],"version-history":[{"count":3,"href":"https:\/\/molecularforecaster.com\/fr\/wp-json\/wp\/v2\/posts\/5312\/revisions"}],"predecessor-version":[{"id":6336,"href":"https:\/\/molecularforecaster.com\/fr\/wp-json\/wp\/v2\/posts\/5312\/revisions\/6336"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/molecularforecaster.com\/fr\/wp-json\/wp\/v2\/media\/5298"}],"wp:attachment":[{"href":"https:\/\/molecularforecaster.com\/fr\/wp-json\/wp\/v2\/media?parent=5312"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/molecularforecaster.com\/fr\/wp-json\/wp\/v2\/categories?post=5312"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/molecularforecaster.com\/fr\/wp-json\/wp\/v2\/tags?post=5312"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}